Cancer

It has been announced today that Philip Morris International (PMI), the American tobacco company, and maker of Marlboro cigarettes, is buying Vectura, the British respiratory drugs company, for £1.04 billion. Vectura has worked on treatments for lung cancer and chronic obstructive pulmonary disease and is the pharmaceutical company responsible for developing a pioneering inhaled treatment
0 Comments
Cancer is one of the greatest global challenges. No one organisation, sector or even country can solve it alone. Just like what we’ve seen with the pandemic, global collaboration and proper investment are what’s needed to drive progress in cancer too. It’s been a terrible year. But even in the worst times, there are silver
0 Comments
Survivorship care typically begins at the end of active treatment. The goal is to provide support and resources for moving forward after treatment. In reality, survivorship care is most helpful when it looks at your whole cancer experience, from diagnosis forward. You are a survivor from day 1. A vital starting point is a baseline
0 Comments
The Pacific Northwest in the U.S. and British Columbia, Canada are being scorched by an unprecedented heat wave this summer. This rare “heat dome” is predicted to only occur once every 1,000 years or so. States across the northwest are breaking records for heat, which is not only incredibly uncomfortable, but extremely dangerous in general
0 Comments
This story was originally shared on The Animal Rescue Site. Submit your own rescue story here. Your story just might be the next to be featured on our blog! I wanted a chihuahua to be a companion to a small one I have that has seizures and sight problems. I thought a friend would help
0 Comments
White bagging is a practice that insurance companies have used for years. It requires patients and hospitals to get special medications such as chemotherapy drugs at insurance-approved formulary pharmacies instead of at their regular pharmacies. Using specialty formulary pharmacies means that each medication is formulated for the patient’s needs instead of mass-produced. Of course, the
0 Comments
The University of Birmingham has partnered with Nonacus, a company that develops non-invasive genetic testing devices, to produce a urine test for bladder cancer that could spare thousands of people invasive procedures. The test will combine Nonacus’ highly sensitive DNA-sensing technology with a set of unique DNA errors (mutations) found in the majority of bladder
0 Comments
How scientific expertise, funding and entrepreneurship came together for the development of an antibody-drug conjugate targeting lymphoma. Oncologists treating diffuse large B-cell lymphoma (DLBCL) have a new medicine in their armoury. In April 2021, following impressive Phase 1 and 2 clinical trial data, the FDA gave accelerated approval to Zynlonta for treating patients with refractory
0 Comments
Roughly 50 percent of cancer patients can benefit from radiotherapy as part of their treatment, and roughly half of those patients are diagnosed early enough that radiation treatment could even be part of their cure, often in combination with chemotherapy and surgery. Radiation is an important cancer therapy, but it also has some hefty side
0 Comments
For women with HER2-positive breast cancer, a common treatment regimen involves combining three different types of chemotherapy drugs: trastuzumab, docetaxel, and carboplatin. Together, these therapies are known as TCbH. However, a new study has shown that adding a fourth drug may improve outcomes for these patients. Pyrotinib is an irreversible second-generation HER2-targeted tyrosine kinase inhibitor
0 Comments